Major Depressive Disorder: 68-Market Analysis and Sales Forecast
Summary
GlobalData estimates that the value of the MDD market in the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and Canada) in 2019 was $4.7 billion. By the end of the forecast period in 2029, GlobalData projects MDD sales to rise to $9.6 billion in the 8MM, at a modest compound annual growth rate (CAGR) of 7.4%.
Across the 68 markets, sales in the MDD market were $8.8 billion in 2019, growing to $16.2 billion in 2029. The eight major markets represent approximately 53.6% and 59.5% of 68-market sales in 2019 and 2029, respectively.
This report covers the 68 geographical markets and provides an Excel-based forecast model for the major depressive disorder (MDD) market through 2029.
Scope
This publication is an expanded version of the Excel model containing the patient-based forecast sales for major depressive disorder (MDD), covered in GlobalData’s report “Major Depressive Disorder: Eight-Market Drug Forecast and Market Analysis - Update”, published in December 2023.
In addition to patient based forecast sales data for the eight major markets (8MM: US, France, Germany, Italy, Spain, UK,Japan, and Canada), this report contains sales forecast extrapolations for an additional 60 geographical markets (60M), totaling 68 markets (68M).
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the 8MM MDD therapeutics market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the 8MM MDD therapeutics market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Please note: this is delivered as a Zip file.
About GlobalData
1 Executive Summary
1.1 Overview
1.2 68M summary statistics
1.3 Key 8MM events driving the 68M forecast extrapolation
2 Appendix
2.1 Abbreviations
2.2 Methodology
2.2.1 Patient-based forecast methodology
2.2.2 68M forecast extrapolation methodology
2.3 Primary research - key opinion leaders interviewed for this report
2.3.1 Key opinion leaders
2.4 Primary research - prescriber survey
2.5 About the authors
2.5.1 Analyst
2.5.2 Therapy area directors
2.5.3 Epidemiologist
2.5.4 Epidemiology reviewers
2.5.5 Vice President of Disease Intelligence and Epidemiology